Editorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives

Affiliations

¹ The Biogerontology Research FoundationOxford, UK; Insilico Medicine Inc.Baltimore, MD, USA; Laboratory of Regenerative Medicine, Federal Research and Clinical Centre of Pediatric Hematology, Oncology and ImmunologyMoscow, Russia.
² Insilico Medicine Inc.Baltimore, MD, USA; Radiation Ecology, Laboratory of Molecular Radiobiology and Gerontology, Institute of Biology of Komi Science Center of Ural Branch of RASSyktyvkar, Russia; Biological and Medical Physics Department, Moscow Institute of Physics and Technology (State University)Dolgoprudny, Russia.

Alex Zhavoronkov et al. Front Genet. 2016.

. 2016 Feb 16:7:17.

doi: 10.3389/fgene.2016.00017. eCollection 2016.

¹ The Biogerontology Research FoundationOxford, UK; Insilico Medicine Inc.Baltimore, MD, USA; Laboratory of Regenerative Medicine, Federal Research and Clinical Centre of Pediatric Hematology, Oncology and ImmunologyMoscow, Russia.
² Insilico Medicine Inc.Baltimore, MD, USA; Radiation Ecology, Laboratory of Molecular Radiobiology and Gerontology, Institute of Biology of Komi Science Center of Ural Branch of RASSyktyvkar, Russia; Biological and Medical Physics Department, Moscow Institute of Physics and Technology (State University)Dolgoprudny, Russia.

No abstract available

Keywords: ICD-11; WHO; aging disease; biogerontology; geroprotectors; longevity risk.

Comment on

Editorial on Research Topic Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives

1. Aliper A. M., Csoka A. B., Buzdin A., Jetka T., Roumiantsev S., Moskalev A., et al. (2015). Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells. Aging 7, 26–37. - PMC - PubMed
1. Duncan D. E. (2012). How Long Do You Want To Live? New York, NY: N. Y. Times.
1. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. (2013). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095–2128. 10.1016/S0140-6736(12)61728-0) - DOI - PMC - PubMed
1. Makarev E., Cantor C., Zhavoronkov A., Buzdin A., Aliper A., Csoka A. B. (2014). Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions. Aging (Albany. NY). 6, 1064–1075. - PMC - PubMed
1. Moskalev A. A., Aliper A. M., Smit-McBride Z., Buzdin A., Zhavoronkov A. (2014). Genetics and epigenetics of aging and longevity. Cell Cycle 13, 1063–1077. 10.4161/cc.28433 - DOI - PMC - PubMed